Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bres

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Pharmaceutical Sciences|November 1, 1985
Quantitative thin-layer and high-performance liquid chromatographic determination of lorapride in biological fluids and a pharmacokinetic study in humansF Bressolle, M C Pistre, J Bres, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1986
[Relative bioavailability in man of 2 pharmaceutical forms of canrenone]F Bressolle, J Bres, A Faure, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1991
Pharmacokinetics of an indomethacin pro-drug: apyramide after intravenous administration in dogM Cociglio, J Bres, D Sauvaire, et al.
British Journal of Clinical Pharmacology|July 1, 1995
Influence of arterio-venous haemofiltration on teicoplanin eliminationD Hillaire-Buys, H Peyriere, E Lobjoie, et al.
International Journal of Pharmaceutics|October 24, 2006
The "in vitro" percutaneous penetration of three antioxidant compoundsG Marti-Mestres, J P Mestres, J Bres, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patientsJ L Pujol, D Cupissol, C Gestin-Boyer, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1989
[Prevention of cisplatin nephrotoxicity in cancer: adjusting the dosage with a computerized chrono-pump]C Gestin-Boyer, C René, D Cupissol, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1993
[Ultradian variations of interleukin-1 beta concentration (IL-1 beta), interferon gamma (IFN-gamma) and soluble IL-2 receptors (RIL-2) in healthy volunteers humen]D Bouayad-Amine, D Cupissol, J Nougier-Soule, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Pharmaceutical Sciences|November 1, 1985
Quantitative thin-layer and high-performance liquid chromatographic determination of lorapride in biological fluids and a pharmacokinetic study in humansF Bressolle, M C Pistre, J Bres, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1986
[Relative bioavailability in man of 2 pharmaceutical forms of canrenone]F Bressolle, J Bres, A Faure, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1991
Pharmacokinetics of an indomethacin pro-drug: apyramide after intravenous administration in dogM Cociglio, J Bres, D Sauvaire, et al.
British Journal of Clinical Pharmacology|July 1, 1995
Influence of arterio-venous haemofiltration on teicoplanin eliminationD Hillaire-Buys, H Peyriere, E Lobjoie, et al.
International Journal of Pharmaceutics|October 24, 2006
The "in vitro" percutaneous penetration of three antioxidant compoundsG Marti-Mestres, J P Mestres, J Bres, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patientsJ L Pujol, D Cupissol, C Gestin-Boyer, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1989
[Prevention of cisplatin nephrotoxicity in cancer: adjusting the dosage with a computerized chrono-pump]C Gestin-Boyer, C René, D Cupissol, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1993
[Ultradian variations of interleukin-1 beta concentration (IL-1 beta), interferon gamma (IFN-gamma) and soluble IL-2 receptors (RIL-2) in healthy volunteers humen]D Bouayad-Amine, D Cupissol, J Nougier-Soule, et al.
Pageof 2